يعرض 261 - 280 نتائج من 21,342 نتيجة بحث عن '(( significant decrease decrease ) OR ( significant ((inter decrease) OR (greatest decrease)) ))*', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 261

    Decreased synthesis of VCAM-1, tubulin and dynein proteins in the heart of mice stimulated with EVs (green) or ICs (blue). حسب Alberto Cornet-Gomez (10676133)

    منشور في 2025
    "…The values represent the mean ± SEM, with significance set at p < 0.05 (*).</p>…"
  2. 262
  3. 263
  4. 264
  5. 265
  6. 266
  7. 267
  8. 268

    NgR1 KO mice exhibited an increase in excitatory synapses and a decrease in inhibitory synapses, indicating an imbalance of synaptic transmission. حسب Jinwei Zhang (462455)

    منشور في 2025
    "…The inhibitory synaptic density of NgR1 mice showed a significant decrease when compared to WT mice (***P <  0.001). …"
  9. 269
  10. 270

    Summary map of all contacts with statistically significant SVM classifications. حسب Alexander P. Rockhill (6053618)

    منشور في 2024
    "…The middle row shows the directionality of spectral change for these significant SVM clusters during number trial conditions versus inter-trial intervals. …"
  11. 271

    Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. حسب Luqiong Liu (11537092)

    منشور في 2024
    "…(<b>C</b>) Y-27632 collaborated with BA to alleviate the decrease in FD-4 flux in LPS-induced Caco2 cells on day 22. …"
  12. 272
  13. 273
  14. 274
  15. 275
  16. 276

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

    منشور في 2025
    "…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
  17. 277
  18. 278
  19. 279

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  20. 280

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"